Tweet
<img alt="" height="1" width="1" />
FDA Okays New Contrast Agent for Neuro MRIs
MedPage Today
A double-strength gadolinium contrast agent for neurological MRI scans, called gadobutrol (Gadavist), may now be marketed in the US, the FDA said. The approval followed a unanimous recommendation in January ...
FDA Approves Gadavist for Central Nervous System ScansPR Newswire (press release)
Bayer's Gadavist is sixth chemical for improving MRI scans approved in USCanadianBusiness.com
Bayer HealthCare Gadavist injection gets FDA approvalPharmaceutical Business Review
The FINANCIAL
all 34 news articles »
More...